Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 8NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Follicular 1Leukemia, Biphenotypic, Acute 1Leukemia 1Anemia, Aplastic 1

Interventions

Rituximab 13Cyclophosphamide 12Vincristine 11Prednisone 11Doxorubicin 8Radiotherapy 6Immunohistochemistry 5VAP-cyclo protocol 4Peripheral Blood Stem Cell Transplantation 4Gene Expression Profiling 4Etoposide 4Amplified Fragment Length Polymorphism Analysis 4tositumomab I-131 3Polymerase Chain Reaction 3Microarray Analysis 3Methotrexate 3Cytarabine 3Melphalan 2Interferon-alpha 2Filgrastim 2Carmustine 2Bortezomib 2Bendamustine Hydrochloride 2thymoglobulin 1sargramostim 1pegfilgrastim 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Follicular × thymoglobulin × Clear all
NCT00737685 2012-03-26

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

The Korean Society of Pediatric Hematology Oncology

Phase 2 Unknown
30 enrolled
Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡